Companion Diagnostics in Oncology

companion diagnostics is divided based on its use for signs or indication, for example, oncology, cardiovascular conditions, central sensory system indication, inflammation and virology. Oncology is the most astounding income generating segment, as majority of the companion diagnostics have been produced for identification of various cancer biomarkers. The key driver for this market is an expansion in innovative work of targeted drugs, which require a corresponding companion diagnostic.

  • Nurse Practitioner Education
  • Pschyatric Nurse Practitioner Education
  • Neonatal Nurse Practitioner Education
  • Family Nurse Practitioner Education
  • Evidence Based Practice in Nursing
  • Advances in Online Nursing Classes
  • Advances in Online Nursing Classes
  • Cancer Screening, Early Detection & Prevention

Related Conference of Companion Diagnostics in Oncology

January 19-20, 2026

27th World Congress on Nursing Care and Healthcare

Amsterdam, Netherlands
January 26-27, 2026

5th World Congress on Nursing Education & Management

Barcelona, Spain
February 12-13, 2026

11th World Congress on Patient Safety & Quality Healthcare

Zurich, Switzerland
March 17-18, 2026

36th World Nursing and Nursing Care Congress

Paris, France
April 20-21, 2026

NURSING CONGRESS 2026

Paris, France
April 28-29, 2026

33rd Global Nursing and Health Care Conference

Amsterdam, Netherlands
April 28-29, 2026

63rd World Nursing Conference

London, UK
May 04-05, 2026

3rd Global Summit on World Nursing

Paris, France
August 03-04, 2026

World Nursing Congress

Toronto, Canada
August 24-25, 2026

33rd Global Nursing and Healthcare Congress

London, UK
October 19-20, 2026

58th Euro Nursing & Medicare Summit

Paris, France

Companion Diagnostics in Oncology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in